{
    "nctId": "NCT03424915",
    "briefTitle": "Exercise, Fitness and Tumor Profiling in Breast Cancer Patients",
    "officialTitle": "Integrative Profiling of Primary Breast Cancer on the Basis of Divergent Exercise Exposure",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 42,
    "primaryOutcomeMeasure": "differences in DNA somatic mutational profile",
    "eligibilityCriteria": "Inclusion Criteria:\n\nCohort 1: Breast Cancer Patients\n\n* Ages 21-80 years\n* Female\n* Histologically confirmed ER receptor positive (\\>1% staining), HER2 negative (FISH ratio \\<1.8), untreated operable breast cancer\n* Stage I to II disease\n* Scheduled for surgical resection by any type of mastectomy or lumpectomy at MSK\n* Tumor size \u22651cm by preoperative imaging or physical examination\n* Categorization into self-reported exercise history exposure classifications as follows: (1) exercising: \u2265120 minutes of vigorous-intensity exercise/wk for the past 12 months, and (2) sedentary (non-exercising): \u2264 30 minutes of moderate-intensity exercise/week for the past months using the Harvard Health Professionals survey.(34)\n* Ability to read and understand English\n* Willing and able to comply with requirements of the protocol\n\nCohort 2: High-Risk Patients\n\n* Women at high-risk of breast cancer, as defined by one of the following:\n\n  * Cytologically confirmed atypical hyperplasia\n  * confirmed LCIS\n  * Being a carrier for BRCA1 and/or BRCA2\n  * Predicted lifetime risk of breast cancer \\>20% based on family history\n  * Predicted 10-year risk of breast cancer of \u22652.31%\n  * Predicted 5-year risk of breast cancer \u22651.67%\n* Aged 21-80 years old\n* If a female of child-bearing potential, must not be pregnant or planning to become pregnant during the study.\n\n  * Women \\<50 years old of child-bearing potential must have a negative pregnancy test (urine HCG or serum) within 14 days of enrollment.\n\nExclusion Criteria:\n\nCohort 1:\n\n* Received any form of neoadjuvant treatment\n* Presence of any other concurrent, actively treated malignancy\n* Presence of metastatic disease\n* If performing a CPET, any of the following contraindications:\n\n  * Acute myocardial infarction within 3-5 days of any planned study procedures;\n  * Unstable angina\n  * Uncontrolled arrhythmia causing symptoms or hemodynamic compromise\n  * Recurrent syncope\n  * Active endocarditis\n  * Acute myocarditis or pericarditis\n  * Symptomatic severe aortic stenosis\n  * Uncontrolled heart failure\n  * Acute pulmonary embolus or pulmonary infarction within 3 months of any planned study procedures\n  * Thrombosis of lower extremities\n  * Suspected dissecting aneurysm\n  * Uncontrolled asthma\n  * Pulmonary edema\n  * Respiratory failure\n  * Acute non-cardiopulmonary disorders that may affect exercise performance or be aggravated by exercise (i.e., infection, renal failure, thyrotoxicosis).\n* Mental impairment leading to inability to cooperate\n* If performing a CPET, room air desaturation at rest \u2264 85%\n* Any other condition or intercurrent illness that, in the opinion of the investigator, makes the participant a poor candidate for the study.\n\nCohort 2:\n\n* Use of any selective estrogen receptor modulator or aromatase inhibitor within 6 months of consent, including, but not limited to: tamoxifen, raloxifene, arzoxifene, acolbifene, anastrozole, exemestane, and letrozole.\n* Enrollment on an interventional investigational study\n* Bilateral breast implants\n* History of any of the following:\n\n  * Invasive breast cancer\n  * DCIS\n* Any current invasive cancer diagnosis\n* Metastatic malignancy of any kind\n* If performing a CPET, any of the following contraindications:\n\n  * Acute myocardial infarction within 3-5 days of any planned study procedures;\n  * Unstable angina\n  * Uncontrolled arrhythmia causing symptoms or hemodynamic compromise\n  * Recurrent syncope\n  * Active endocarditis\n  * Acute myocarditis or pericarditis\n  * Symptomatic severe aortic stenosis\n  * Uncontrolled heart failure\n  * Acute pulmonary embolus or pulmonary infarction within 3 months of any planned study procedures\n  * Thrombosis of lower extremities\n  * Suspected dissecting aneurysm\n  * Uncontrolled asthma\n  * Pulmonary edema\n  * Respiratory failure\n  * Acute non-cardiopulmonary disorders that may affect exercise performance or be aggravated by exercise (i.e., infection, renal failure, thyrotoxicosis).\n* Mental impairment leading to inability to cooperate\n* If performing a CPET, room air desaturation at rest \u2264 85%\n* Any other condition or intercurrent illness that, in the opinion of the investigator, makes the participant a poor candidate for the core biopsy or the study.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}